SYNLOGIC, INC. Net Income (Loss) Available to Common Stockholders, Basic
SYNLOGIC, INC. (SYBX) reported Net Income (Loss) Available to Common Stockholders, Basic of $4.98 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2017-05-09
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-03-31 was $4.98M, a 24.26% decline year-over-year.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-12-31 was -$8.69M.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-09-30 was -$5.37M.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-06-30 was -$5.64M.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for fiscal 2016 was -$26.27M.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$29.30M.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for fiscal 2014 was -$18.66M.
- SYNLOGIC, INC. net income (loss) available to common stockholders, basic for fiscal 2013 was -$8.76M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | $4.98M 10-Q · filed 2017-05-09 | -$3.72M derived: sum of 2 quarters · filed 2017-05-09 | -$9.08M derived: sum of 3 quarters · filed 2017-05-09 | -$14.72M derived: sum of 4 quarters · filed 2017-05-09 | |
| 2016-12-31 | -$8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$14.06M derived: sum of 2 quarters · filed 2017-03-15 | -$19.70M derived: sum of 3 quarters · filed 2017-03-15 | -$26.27M 10-K · filed 2017-03-15 | |
| 2016-09-30 | -$5.37M 10-Q · filed 2016-11-10 | -$11.00M derived: sum of 2 quarters · filed 2016-11-10 | -$17.57M 10-Q · filed 2016-11-10 | -$13.32M derived: sum of 4 quarters · filed 2017-05-09 | |
| 2016-06-30 | -$5.64M 10-Q · filed 2016-08-15 | -$12.21M 10-Q · filed 2016-08-15 | -$7.96M derived: sum of 3 quarters · filed 2017-05-09 | -$15.74M derived: sum of 4 quarters · filed 2017-05-09 | |
| 2016-03-31 | $6.57M 10-Q · filed 2017-05-09 | -$6.57M 10-Q · filed 2016-05-12 | -$2.32M derived: sum of 2 quarters · filed 2017-05-09 | -$10.10M derived: sum of 3 quarters · filed 2017-05-09 | -$17.33M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$8.89M 10-K · filed 2017-03-15 | -$16.68M derived: sum of 2 quarters · filed 2017-03-15 | -$23.90M derived: sum of 3 quarters · filed 2017-03-15 | -$29.30M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$7.79M 10-K · filed 2017-03-15 | -$15.01M derived: sum of 2 quarters · filed 2017-03-15 | -$20.41M 10-Q · filed 2016-11-10 | -$25.50M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | -$7.23M 10-K · filed 2017-03-15 | -$12.63M 10-Q · filed 2016-08-15 | -$17.72M derived: sum of 3 quarters · filed 2017-03-15 | -$23.85M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | -$5.40M 10-K · filed 2017-03-15 | -$10.49M derived: sum of 2 quarters · filed 2017-03-15 | -$16.62M derived: sum of 3 quarters · filed 2017-03-15 | -$20.32M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-12-31 | -$5.09M 10-K · filed 2016-03-30 | -$11.22M derived: sum of 2 quarters · filed 2016-03-30 | -$14.93M derived: sum of 3 quarters · filed 2016-03-30 | -$18.66M 10-K · filed 2017-03-15 | |
| 2014-09-30 | -$6.13M 10-K · filed 2016-03-30 | -$9.84M derived: sum of 2 quarters · filed 2016-03-30 | -$13.57M 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | -$3.70M 10-K · filed 2016-03-30 | -$7.43M derived: sum of 2 quarters · filed 2016-03-30 | |||
| 2014-03-31 | -$3.73M 10-K · filed 2016-03-30 | ||||
| 2013-12-31 | -$8.76M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |